Loading
A phase 2 trial of Whole-body MRI in Prostate cancer, run by University College London Hospitals, with a status the registry has not verified recently.
FOcal RECurrent Assessment and Salvage Treatment is a phase 2 interventional study registered as NCT01883128 by University College London Hospitals, with 177 participants planned, started 2014-04 and due to reach its primary completion in 2019-10. Interventions recorded: Whole Body MRI, Focal Salvage Therapy, MRI Targeted biopsies. Conditions recorded: Progression of Prostate Cancer.
Linked to the technology Whole-body MRI because the registry names it ("whole body mri") among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Whole-body MRI, Prostate cancer and the tag pipeline.
Shares Whole-body MRI, Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/